Downstream signaling pathways of PI3K involve AKT and mTOR, while phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), encoding the catalytic subunit p110α of the PI3K complex, is frequently mutated and amplified in various cancer types. Here, PIK3CA is linked to cancer.